Sardido, Renilda M.
HRN: 20-96-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2023
METRONIDAZOLE 500MG (TAB)
10/28/2023
11/04/2023
PO
500mg
TID X 7 Days
S/P NSVD; Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes